MVision AI is a Finnish cloud-based software provider that uses artificial intelligence to automate radiotherapy treatment planning via automatic segmentation and standardized contouring. Its models support oncologists by streamlining the treatment-planning workflow, reducing hospital costs and patient wait times, and enabling same-day treatment in some cases. The company reports its technology has been used to treat more than 100,000 patients to date. Founded in 2017 by Mahmudul Hasan, Jarkko Niemelä and Saad Ullah Akram, MVision emphasizes faster, more reliable clinical decision-making while preserving human patient care. The company plans to use new funding to develop additional solutions to speed treatment and to build a globally scalable platform.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2023